C. Rosorius et al. / Journal of Organometallic Chemistry 744 (2013) 149e155
153
1
1
d
¼ 148.0 (d, JFC w 251 Hz, C6F5), 143.4 (d, JFC w 256 Hz, C6F5),
NMR (151 MHz, CD2Cl2, 299 K):
d
¼ 159.5 (d, 1JPC ¼ 117.6 Hz, C]O),
138.2 (d, 1JFC w 254 Hz, C6F5), 132.3 (d, 4JPC ¼ 2.3 Hz, o-Ph), 130.4 (p-
155.6 (d, 2JPC ¼ 5.3 Hz, ]CH),141.1 (d, 3JPC ¼ 11.7 Hz, i-PhB), 136.6 (d,
3JPC ¼ 14.4 Hz, i-PhA), 130.8 (p-PhA), 128.9 (m-PhA), 128.8 (o-PhB),
128.0 (o-PhA), 127.0 (p-PhB),126.3 (br, PCB)a, 124.8 (m-PhB), 118.7 (br,
3
Ph), 128.9 (m-Ph), 121.8 (d, JPC
¼
1.4 Hz, i-Ph), 109.9 (d,
2JPC ¼ 14.5 Hz, ^C-Ph), 107.8 (m, i-C6F5), 77.4 (m, PeC^). 19F NMR
i-C6FB5), 94.8 (dm, JPC ¼ 78.7 Hz, i-C6F5P) [C6F5: not listed, from
1
a
(564 MHz, CD2Cl2, 298 K):
d
¼ ꢀ130.3 (2F, o), ꢀ150.0 (1F, p), ꢀ161.0
(2F, m) (each m) [Ddpm ¼ 11.0]. 31P{1H} NMR (243 MHz, CD2Cl2,
GHMBC experiment]. 11B{1H} NMR (192 MHz, CD2Cl2, 299 K):
3
298 K):
d
¼ ꢀ82.3 (quin, JPF ¼ 31.6 Hz).
d
¼ ꢀ4.0 (n1/2 w80 Hz). 19F NMR (564 MHz, CD2Cl2, 298 K):
¼ ꢀ125.2 (br, 2F, o), ꢀ137.6 (m, 1F, p), ꢀ156.4 (m, 2F, m) (PC6F5)
d
4.3. Preparation of compound 5
[
Ddpm ¼ 18.8], ꢀ132.2 (br, 2F, o), ꢀ157.6 (m, 1F, p), ꢀ164.5 (m, 2F, m)
(BC6F5) [Ddpm ¼ 6.9]. 31P NMR (243 MHz, CD2Cl2, 299 K):
d
¼ ꢀ25.7
3
Compound 4 (3.00 g, 6.43 mmol, 1.0 eq) was added to a sus-
pension of bis(pentafluorophenyl)borane (2.22 g, 6.43 mmol,
1.0 eq) in n-pentane (80 mL) at 0 ꢁC. Upon warming up to room
temperature and stirring for 2 h the colour of the solution turned
from orange to yellow. The solvent was removed in vacuo and
product 5 was obtained as a bright yellow solid (4.71 g, 5.79 mmol,
90%). Crystals suitable for the X-ray crystal structure analysis were
obtained by slow evaporation of a saturated solution of 5 in
dichloromethane at ꢀ34 ꢁC. Anal. Calcd. for C32H6BF20P: C, 47.32; H,
0.74. Found: C 48.13, H 1.07. Mp: 131 ꢁC (DSC). 1H NMR (500 MHz,
(dm, JPH w 60 Hz). 31P{1H} NMR (243 MHz, CD2Cl2, 299 K):
d
¼ ꢀ25.7 (n1/2 w40 Hz).
4.4.3. Preparation of compound 7
Compound 5 (200 mg, 0.246 mmol, 1 eq) was reacted with
benzaldehyde (26 mg, 0.246 mmol, 1 eq) to yield 7 as a white solid
(115 mg, 0.125 mmol, 51%). Crystals suitable for the X-ray crystal
structure analysis were obtained by slow evaporation of a saturated
solution of 7 in dichloromethane at ꢀ34 ꢁC. Anal. Calcd. for
C39H12BF20OP: C, 51.01; H 1.32. Found: C, 51.16; H, 1.48. Mp: 178 ꢁC
CD2Cl2, 299 K):
d
¼ 7.86 (d, 3JPH ¼ 20.0 Hz, 1H, ]CH), 7.38 (m, 2H, o-
(DSC). 1H NMR (600 MHz, CD2Cl2, 299 K):
d
¼ 8.53 (d, 3JPH ¼ 62.8 Hz,
Ph), 7.27 (m, 2H, m-Ph), 7.25 (m, 1H, p-Ph). 13C{1H} NMR (126 MHz,
1H, ]CH), 7.37 (m, 1H, p-PhB), 7.27 (m, 2H, m-PhB), 7.23 (m, 1H, p-
PhA), 7.17 (m, 2H, m PhA), 7.15 (m, 2H, o-PhB), 7.04 (m, 2H, o-PhA),
CD2Cl2, 299 K):
d
¼ 158.1 (d, 2JPC ¼ 8.8 Hz, ]CH), 143.0 (m br, PCB)a,
2
137.0 (i-Ph), 130.3 (d, J ¼ 1.1 Hz, p-Ph), 128.9 (m-Ph), 128.4 (d,
6.19 (d, JPH ¼ 14.9 Hz, 1H, OCH). 13C{1H} NMR (151 MHz, CD2Cl2,
4JPC ¼ 6.1 Hz, o-Ph), [C6F5 not listed, a from GHMBC experiment]. 11
B
299 K):
d
¼ 159.4 (]CH), 139.5 (d, JPC ¼ 13.5 Hz, i-PhA), 137.4 (br,
3
{1H} NMR (160 MHz, CD2Cl2, 299 K):
d
¼ 59.3 (br, n1/2 w1500 Hz).
PCB)a, 133.4 (m, i-PhB), 130.5 (d, 5JPC ¼ 4.7 Hz, p-PhB), 129.5 (p-PhA),
129.0 (d, 4JPC ¼ 3.7 Hz, m-PhB),128.9 (m-PhA),126.69 (o-PhA),126.61
11B{1H} MAS (nrot ¼ 14 kHz, 11.74 T):
d
¼ 57.9 (CQ ¼ 4.23 MHz,
3
1
h
¼ 0.14). 19F NMR (470 MHz, CD2Cl2, 299 K):
d
¼ ꢀ127.1 (br, 2F,
(d, JPC ¼ 5.4 Hz, o-PhB), 85.4 (d, JPC ¼ 47.5 Hz, OCH) [C6F5: not
o), ꢀ149.6 (m, 1F, p), ꢀ161.0 (m, 2F, m) (PC6F5) [Ddpm ¼ 11.4], ꢀ128.1
(2F, o), ꢀ147.0 (1F, p), ꢀ160.8 (2F, m) (each m, BC6F5) [Ddpm ¼ 13.8].
listed, a from GHMBC experiment]. 11B{1H} NMR (192 MHz, CD2Cl2,
299 K):
d
¼ 0.7 (n1/2 w80 Hz). 19F NMR (470 MHz, CD2Cl2, 299 K):
31P{1H} NMR (202 MHz, CD2Cl2, 299 K):
d
¼ ꢀ48.2 (m). 31P{1H}
d
¼ ꢀ124.1, ꢀ125.7 (each br, each 2F, each o), ꢀ139.3, ꢀ140.2 (each
CPMAS (nrot ¼ 10 kHz, 7.05 T):
d
¼ ꢀ47.4.
m, each 1F, each p), ꢀ157.0 (m), ꢀ158.4 (br) (each 2F, each m,
X-ray crystal structure analysis of compound 5: Formula
C32H6BF20P ꢃ CH2Cl2, M ¼ 897.07, yellow crystal, 0.24 ꢃ 0.12 ꢃ
PC6F5), ꢀ132.0 (m, 2F, o), ꢀ159.3 (t, 3JFF ¼ 19.8 Hz, 1F, p), ꢀ165.1 (m,
2F, m) (BC6Fa5) [Dd
F
pm
¼ 5.8], ꢀ135.2 (m, 2F, o), ꢀ160.6 (t,
19
19
0.12 mm, a ¼ 11.2024(5), b ¼ 12.4598(3)ꢁ, c ¼ 14.3586(11) A,
3JFF ¼ 19.7 Hz, 1F, p), ꢀ165.6 (m, 2F, m) (BC6Fb5) [Dd
F
¼ 5.0]. 31
P
ꢀ
pm
3
ꢀ
3
a
¼ 68.421(3),
b
¼ 85.294(4),
g
¼ 63.618(3) , V ¼ 1661.61(15) A ,
NMR (243 MHz, CD2Cl2, 299 K): d
¼ ꢀ2.2 (dm, JPH w 63 Hz). 31P
rcalc ¼ 1.793 g cmꢀ3
,
m
¼ 3.531 mmꢀ1, empirical absorption
{1H} NMR (243 MHz, CD2Cl2, 299 K):
d
¼ ꢀ2.2 (n1/2 w50 Hz).
correction (0.484 ꢄ T ꢄ 0.676), Z ¼ 2, triclinic, space group P1 (No.
X-ray crystal structure analysis of compound 7: Formula
C39H12BF20OP ꢃ CH2Cl2, M ¼ 1003.19, colourless crystal, 0.35 ꢃ
ꢀ
2),
l
¼ 1.54178 A, T ¼ 223(2) K,
u and 4 scans, 18934 reflections
] ¼ 0.60 Åꢀ1, 5657 independent
0.32 ꢃ 0.10 mm, a ¼ 11.4027(4), b ¼ 21.0993(5), c ¼ 16.1444(3) A,
ꢀ
collected (ꢂh, ꢂk, ꢂl), [(sin
q)/l
(Rint ¼ 0.059) and 4742 observed reflections [I > 2
s
(I)], 542 refined
b
¼ 96.181(2) , V ¼ 3861.58(18) A , rcalc ¼ 1.726 g cmꢀ3
,
m
¼
3
ꢀ
ꢁ
parameters, R ¼ 0.057, wR2 ¼ 0.171, max. (min.) residual electron
3.136 mmꢀ1, empirical absorption correction (0.406 ꢄ T ꢄ 0.744,
ꢀꢀ3
ꢀ
density 0.50 (ꢀ0.41) e.A , hydrogen atoms were calculated and
Z ¼ 4), monoclinic, space group P21/n (No. 14),
l
¼ 1.54178 A,
refined as riding atoms.
T ¼ 223(2) K,
u
and 4 scans, 37748 reflections collected (ꢂh, ꢂk, ꢂl),
[(sin )/
q
l
] ¼ 0.60 Åꢀ1, 6708 independent (Rint ¼ 0.044) and 6116
4.4. Reaction of 5 with small molecules
observed reflections [I > 2
s
(I)], 614 refined parameters, R ¼ 0.048,
wR2
¼
0.124, max. (min.) residual electron density 0.51
ꢀꢀ3
4.4.1. General procedure
(ꢀ0.39) e A , hydrogen atoms were calculated and refined as
Compound 5 was dissolved in n-pentane (5 mL) and then
treated with a solution of the respective substrate (1 eq) in n-
pentane (2e3 mL) at room temperature. Upon stirring the reaction
mixture for 12 h at room temperature the resulting precipitate was
collected and washed with n-pentane (3 ꢃ 4e8 mL). Subsequently
the obtained solid was dried in vacuo to get the respective product.
riding atoms.
4.4.4. Preparation of compound 8
Compound 5 (200 mg, 0.25 mmol, 1.0 eq) was reacted with
cinnamic aldehyde (33 mg, 0.25 mmol, 1.0 eq) to give 8 as a white
solid (115 mg, 0.125 mmol, 51%). Elemental Analysis: calcd. for
C41H14BF20OP: C, 52.15; H, 1.49. Found: C, 52.31; H, 1.72. Dp: 182 ꢁC
4.4.2. Preparation of compound 6
(DSC). 1H NMR (600 MHz, CD2Cl2, 299 K):
d
¼
8.49 (d,
Caution: Many isocyanates are toxic and must be handled with
due care. Compound 5 (200 mg, 0.25 mmol, 1.0 eq) was reacted
with phenylisocyanate (29 mg, 0.25 mmol, 1.0 eq) to give 6 as a
white solid (183 mg, 0.197 mmol, 80%). Anal. Calcd. for
C39H11BF20NOP: C, 50.30; H, 1.19; N,1.50. Found: C, 50.25; H, 1.41; N,
3JPH ¼ 63.0 Hz, 1H, ]CH), 7.33 (m, 2H, m-PhB)a, 7.31 (m,
1H, p-PhB)a, 7.28 (br, 2H, o-PhB), 7.24 (m, 1H, p-PhA), 7.19 (m,
2H, m-PhA), 7.07 (m, 2H, o-PhA), 6.79 (m, 1H, ]CHPh)t, 6.23 (m,
1H,]CHCH)t, 5.83 (m, 1H, OCH) [a from GHMBC and GHSQC
t
experiment,
tentative assignment]. 13C{1H} NMR (151 MHz,
d
1.24. Dp: 178 ꢁC (DSC). 1H NMR (600 MHz, CD2Cl2, 299 K):
d
¼ 8.05
CD2Cl2, 299 K):
¼ 159.3 (br, ]CH), 139.4 (d, 3JPC ¼ 14.0 Hz, i-PhA),
(d, JPH ¼ 60.6 Hz, 1H, ]CH), 7.29 (m, 1H, p-PhA)a, 7.25 (m, 2H, m-
137.1 (br, PCB)a, 135.6 (br, ]CHPh a t, 135.5 (br, i-PhB), 129.6 (p-PhA),
)
3
PhA)a, 7.21 (m, 2H, m-PhB)a, 7.20 (m, 2H, o-PhB)a, 7.18 (m, 2H, o-
129.3 (br, p-PhB), 129.2 (m-PhB), 128.9 (m-PhA), 127.0 (br, o-PhB),
126.8 (d, 4JPC ¼ 2.0 Hz, o-PhA), 120.1 (br, ]CHCH)t, 96.8 (br, i-C6F5),
PhA)a, 7.09 (m, 1H, p-PhB)a
[
from GHSQC experiment]. 13C{1H}
a